Biocare, a new service by Aramex, which operates as part of the cold supply chain category, will now be available in prominent markets for the company. The new service offering will be integral to hospitals, laboratories, and pharmaceutical companies that require a facility to move clinical material and medical samples in a temperature controlled facility.
The Biocare facility will allow samples and specimens to remain in temperature controlled conditions for up to 72 hours enabling safe transportation to domestic and worldwide locations. Biocare ensures clients a complete package solution in the delivery of items via an in-built monitoring system. Management of the process also includes the handling of documentation required for timely customs clearance so that delivery deadlines are met. The new Biocare system was tested during a pilot program in the Middle East and was later trialed in Africa and Asia.
The service is expected to commence operation in a number of markets over the next year. The arrival of the Biocare system has come about due to research into gaps in the market for cold supply chain solutions. Global Director of Customer Relationship Management for Aramex, Sami Hammoudeh, commented on the rationale for the new offering, “Aramex identified a need in the market, as the healthcare industry wanted an end-to-end solution for moving clinical specimens and medical samples to different destinations. We developed the Biocare solution after interviewing customers and understanding their exact needs”. Hammoudeh goes on to discuss the issue of damaged clinical and medical material due to unsatisfactory transporting and sees the new solution as key in the prevention of these instances in the future. Biocare’s launch comes at a time where it projected that the global health market will reach an estimated value of $43.9 billion by 2015. This figure, along with projections for population growth, creates a greater need for sustained and efficient cold supply chain logistical systems to be in place.